Clin Mol Hepatol.
2025 Apr;31(2):592-595. 10.3350/cmh.2024.0971.
Stabilizing hepatic fatty acid oxidation: Editorial on “USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination”
- Affiliations
-
- 1College of Pharmacy, Seoul National University, Seoul, Korea
- 2Research Institute of Pharmaceutical Sciences and Natural Products Research Institute, Seoul National University, Seoul, Korea
- KMID: 2566981
- DOI: http://doi.org/10.3350/cmh.2024.0971
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- USP29 alleviates the progression of MASLD by stabilizing ACSL5 through K48 deubiquitination
- AMPK Activator AICAR Inhibits Hepatic Gluconeogenesis and Fatty Acid Oxidation
- Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
- PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
- TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD
